Search DCTH
DELCATH SYSTEMS, INC.
Nasdaq · CIK 872912
Last close15.13
Daily change-0.28 (-1.82%)
10 Years gain-98.40%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
DCTH · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 1231
Fundamental
63.3Momentum
100.0Acceleration
100.0Confidence
88.0Annual Revenue13
Quarterly Revenue42
Annual CFO14
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth25.0 / 25
Quality15.6 / 25
Capital Efficiency4.5 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 3.678 percentage points.
Operating leverageOperating margin improved by 38.3427 percentage points.
ROIC expansionROIC improved by 134.5855 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Key Metrics
Revenue Growth TTM135.97%OK
Revenue CAGR 3Y215.3%OK
Gross Margin87.19%OK
Operating Margin2.99%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC7.21%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y0.63%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $85.23M | $73.43M | $660,000.00 | $22.52M | $20.97M | 86.16% | 0.77% | 24.6% | 2.84% | 39.92M |
| 2025 FY Dec 31, 2024 | $37.21M | $31.02M | -$12.41M | -$18.68M | -$19.24M | 83.37% | -33.36% | -51.71% | -218.2% | 28.51M |
| 2024 FY Dec 31, 2023 | $2.07M | $1.43M | -$38.18M | -$31.25M | -$31.31M | 69.25% | -1,849.01% | -1,516.17% | n/a | 16.23M |
| 2023 FY Dec 31, 2022 | $2.72M | $2.03M | -$33.85M | -$24.95M | -$25.16M | 74.77% | -1,245.05% | -925.3% | n/a | 8.86M |
| 2022 FY Dec 31, 2021 | $3.56M | $2.88M | -$24.53M | -$22.60M | -$22.75M | 81.13% | -690.04% | -639.86% | n/a | 7.15M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $98.85M | sum latest 4 fiscal quarters Revenue | OK | 0001628280-26-053956, 0001628280-25-048558 |
| Revenue Growth TTM | 135.97% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001628280-26-053956, 0001628280-25-048558 |
| Revenue CAGR 3Y | 215.3% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001628280-26-012019 |
| Revenue CAGR 5Y | 99.24% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001628280-26-012019 |
| Gross Profit CAGR 3Y | 230.56% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001628280-26-012019 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001628280-26-053956, 0001628280-25-048558 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 87.19% | Gross Profit / Revenue | OK | 0001628280-26-053956, 0001628280-25-048558 |
| Operating Margin | 2.99% | Operating Income / Revenue | OK | 0001628280-26-053956, 0001628280-25-048558 |
| ROIC | 7.21% | NOPAT / Average Invested Capital | OK | 0001628280-26-053956, 0001628280-25-048558 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001628280-26-053956 |
| Current Ratio | 9.83x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $2.49 | Revenue / Diluted Shares | OK | 0001628280-26-053956, 0001628280-25-048558 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |